Condition
Sarcoma Uterus
Total Trials
5
Recruiting
2
Active
4
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Active Not Recruiting2
Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05515575Phase 2Active Not Recruiting
A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
NCT04250766Not ApplicableActive Not Recruiting
Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR)
NCT04990076Recruiting
Ultrasound Evaluation of the Myometrium Using the MUSA Terminology Comparison With Histology
NCT05610501Recruiting
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
NCT04123158CompletedPrimary
MYometrial Lesion UltrasouNd And mRi
Showing all 5 trials